Newsmeme!
Discover News you didn't know existed
Over the last 25 years, a family owned nutritional supplement manufacturer in Milford, Connecticut, has been developing pet supplements to promote good health in dogs and cats all over the world. Scott Brown, owner, has finally solved common skin infection in dogs with his new supplemenets. The nutritional supplement has helped dogs such as Laika (a Samoyed) regain all of her lost hair due to ...
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
Experts warn that older antihistamines in over-the-counter allergy medications -- the most common form of self-medication in allergic rhinitis -- may be hazardous to our health. A position paper reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines.
KNOXVILLE, Tenn.----Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled “A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr.
WOODSTOCK – On Saturday, the Environmental Defenders of McHenry County once again will conduct a recycling drive to collect household batteries, fluorescent tubes, and compact fluorescent light bulbs.
Dr Martin Scurr has been treating patients for more than 30 years and is one of the country's leading GPs. Here he offers advice to a patient suffering from restless legs syndrome.
MISSISSAUGA, ON, Feb. 8 /PRNewswire-FirstCall/ - YM BioSciences Inc.
YM BioSciences Inc. , today reported operational and financial results for the second quarter of fiscal 2010, ended December 31, 2009.
Paloma Pharmaceuticals Inc. Posted on:05 Feb 10 JAMAICA PLAIN, Massachusetts, February 4 /PRNewswire/ -- Paloma Pharmaceuticals, Inc. announced today that it has received acceptance of its IND to enter Phase I studies with Palomid 529 (P529) in patients with age-related macular degeneration (AMD). The Phase I study, "A Phase I Open-Label Study to Investigate the Safety, Tolerability and ...
Q: I have had to deal with eczema since I was a child. The worst part of it is the itching. I try not to scratch, but during sleep I do it without waking. I have seen several doctors. Are there any new ideas?
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |